Prognostic impact of peripelvic fat invasion in pT3 renal pelvic transitional cell carcinoma

Su Cho Kang, Hoon Cho Nam, Yul Park Sung, Yong Cho Sung, Deuk Choi Young, Ha Chung Byung, Choul Yang Seung, Joon Hong Sung

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Renal pelvic transitional cell carcinoma (TCC), which invades beyond muscularis into peripelvic fat or the renal parenchyma, is diagnosed as stage pT3 despite its structural complexity. We evaluated the prognostic impact of peripelvic fat invasion in pT3 renal pelvic TCC. Between 1986 and 2004, the medical records on 128 patients who were surgically treated for renal pelvic TCC were retrospectively reviewed. Sixty patients with pT3 disease were eligible for the main analysis. The prognostic impact of various clinicopathological factors was analyzed using univariate and multivariate analyses. On univariate analysis, sex, age, concomitant bladder tumors, concomitant ureter tumors, lymphadenectomy, adjuvant chemotherapy, tumor grade, multiplicity, renal parenchymal invasion, and carcinoma in situ did not influence the disease-specific survival (p>0.05). By contrast, peripelvic fat invasion, lymph node invasion, and lymphovascular invasion were each significantly associated with disease-specific survival (p<0.05). Multivariate analysis showed that peripelvic fat invasion (p=0.012) and lymph node invasion (p=0.004) were independent prognostic factors. In conclusion, peripelvic fat invasion is a strong prognostic factor in pT3 renal pelvic TCC. Thus, systemic adjuvant therapy should be considered in the presence of peripelvic fat invasion, even if the lymph nodes are not involved.

Original languageEnglish
Pages (from-to)434-438
Number of pages5
JournalJournal of Korean medical science
Volume23
Issue number3
DOIs
Publication statusPublished - 2008 Jun 1

Fingerprint

Transitional Cell Carcinoma
Fats
Kidney
Lymph Nodes
Multivariate Analysis
Survival
Carcinoma in Situ
Adjuvant Chemotherapy
Ureter
Lymph Node Excision
Urinary Bladder Neoplasms
Medical Records
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kang, Su Cho ; Nam, Hoon Cho ; Sung, Yul Park ; Sung, Yong Cho ; Young, Deuk Choi ; Byung, Ha Chung ; Seung, Choul Yang ; Sung, Joon Hong. / Prognostic impact of peripelvic fat invasion in pT3 renal pelvic transitional cell carcinoma. In: Journal of Korean medical science. 2008 ; Vol. 23, No. 3. pp. 434-438.
@article{78f81b403ffc4bbbb1d66e26e2d7ac71,
title = "Prognostic impact of peripelvic fat invasion in pT3 renal pelvic transitional cell carcinoma",
abstract = "Renal pelvic transitional cell carcinoma (TCC), which invades beyond muscularis into peripelvic fat or the renal parenchyma, is diagnosed as stage pT3 despite its structural complexity. We evaluated the prognostic impact of peripelvic fat invasion in pT3 renal pelvic TCC. Between 1986 and 2004, the medical records on 128 patients who were surgically treated for renal pelvic TCC were retrospectively reviewed. Sixty patients with pT3 disease were eligible for the main analysis. The prognostic impact of various clinicopathological factors was analyzed using univariate and multivariate analyses. On univariate analysis, sex, age, concomitant bladder tumors, concomitant ureter tumors, lymphadenectomy, adjuvant chemotherapy, tumor grade, multiplicity, renal parenchymal invasion, and carcinoma in situ did not influence the disease-specific survival (p>0.05). By contrast, peripelvic fat invasion, lymph node invasion, and lymphovascular invasion were each significantly associated with disease-specific survival (p<0.05). Multivariate analysis showed that peripelvic fat invasion (p=0.012) and lymph node invasion (p=0.004) were independent prognostic factors. In conclusion, peripelvic fat invasion is a strong prognostic factor in pT3 renal pelvic TCC. Thus, systemic adjuvant therapy should be considered in the presence of peripelvic fat invasion, even if the lymph nodes are not involved.",
author = "Kang, {Su Cho} and Nam, {Hoon Cho} and Sung, {Yul Park} and Sung, {Yong Cho} and Young, {Deuk Choi} and Byung, {Ha Chung} and Seung, {Choul Yang} and Sung, {Joon Hong}",
year = "2008",
month = "6",
day = "1",
doi = "10.3346/jkms.2008.23.3.434",
language = "English",
volume = "23",
pages = "434--438",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "3",

}

Prognostic impact of peripelvic fat invasion in pT3 renal pelvic transitional cell carcinoma. / Kang, Su Cho; Nam, Hoon Cho; Sung, Yul Park; Sung, Yong Cho; Young, Deuk Choi; Byung, Ha Chung; Seung, Choul Yang; Sung, Joon Hong.

In: Journal of Korean medical science, Vol. 23, No. 3, 01.06.2008, p. 434-438.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic impact of peripelvic fat invasion in pT3 renal pelvic transitional cell carcinoma

AU - Kang, Su Cho

AU - Nam, Hoon Cho

AU - Sung, Yul Park

AU - Sung, Yong Cho

AU - Young, Deuk Choi

AU - Byung, Ha Chung

AU - Seung, Choul Yang

AU - Sung, Joon Hong

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Renal pelvic transitional cell carcinoma (TCC), which invades beyond muscularis into peripelvic fat or the renal parenchyma, is diagnosed as stage pT3 despite its structural complexity. We evaluated the prognostic impact of peripelvic fat invasion in pT3 renal pelvic TCC. Between 1986 and 2004, the medical records on 128 patients who were surgically treated for renal pelvic TCC were retrospectively reviewed. Sixty patients with pT3 disease were eligible for the main analysis. The prognostic impact of various clinicopathological factors was analyzed using univariate and multivariate analyses. On univariate analysis, sex, age, concomitant bladder tumors, concomitant ureter tumors, lymphadenectomy, adjuvant chemotherapy, tumor grade, multiplicity, renal parenchymal invasion, and carcinoma in situ did not influence the disease-specific survival (p>0.05). By contrast, peripelvic fat invasion, lymph node invasion, and lymphovascular invasion were each significantly associated with disease-specific survival (p<0.05). Multivariate analysis showed that peripelvic fat invasion (p=0.012) and lymph node invasion (p=0.004) were independent prognostic factors. In conclusion, peripelvic fat invasion is a strong prognostic factor in pT3 renal pelvic TCC. Thus, systemic adjuvant therapy should be considered in the presence of peripelvic fat invasion, even if the lymph nodes are not involved.

AB - Renal pelvic transitional cell carcinoma (TCC), which invades beyond muscularis into peripelvic fat or the renal parenchyma, is diagnosed as stage pT3 despite its structural complexity. We evaluated the prognostic impact of peripelvic fat invasion in pT3 renal pelvic TCC. Between 1986 and 2004, the medical records on 128 patients who were surgically treated for renal pelvic TCC were retrospectively reviewed. Sixty patients with pT3 disease were eligible for the main analysis. The prognostic impact of various clinicopathological factors was analyzed using univariate and multivariate analyses. On univariate analysis, sex, age, concomitant bladder tumors, concomitant ureter tumors, lymphadenectomy, adjuvant chemotherapy, tumor grade, multiplicity, renal parenchymal invasion, and carcinoma in situ did not influence the disease-specific survival (p>0.05). By contrast, peripelvic fat invasion, lymph node invasion, and lymphovascular invasion were each significantly associated with disease-specific survival (p<0.05). Multivariate analysis showed that peripelvic fat invasion (p=0.012) and lymph node invasion (p=0.004) were independent prognostic factors. In conclusion, peripelvic fat invasion is a strong prognostic factor in pT3 renal pelvic TCC. Thus, systemic adjuvant therapy should be considered in the presence of peripelvic fat invasion, even if the lymph nodes are not involved.

UR - http://www.scopus.com/inward/record.url?scp=46849084751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46849084751&partnerID=8YFLogxK

U2 - 10.3346/jkms.2008.23.3.434

DO - 10.3346/jkms.2008.23.3.434

M3 - Article

C2 - 18583879

AN - SCOPUS:46849084751

VL - 23

SP - 434

EP - 438

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 3

ER -